Home
/
ASSEMBLY BIOSCIENCES, INC.
/
Financials
/
Quarterly
ASSEMBLY BIOSCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ASSEMBLY BIOSCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Mar 31, 2019
$3.89M
May 9, 2019
Q3
2018
Sep 30, 2018
$4.29M
Nov 8, 2018
Q2
2018
Jun 30, 2018
$3.22M
Aug 8, 2018
Q1
2019
Mar 31, 2018
$3.57M
May 9, 2019
Q3
2018
Sep 30, 2017
$2.66M
Nov 8, 2018
Q2
2018
Jun 30, 2017
$2.36M
Aug 8, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.20M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($10.20M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($8.82M)
May 8, 2025
Q3
2025
Sep 30, 2024
($9.61M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($11.15M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($9.08M)
May 8, 2025
Q3
2024
Sep 30, 2023
($14.42M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($16.90M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($18.95M)
May 8, 2024
Q3
2023
Sep 30, 2022
($23.15M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($24.46M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($23.09M)
May 4, 2023
Q3
2022
Sep 30, 2021
($18.80M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($23.60M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($27.20M)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.35M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
$7.27M
Aug 5, 2021
Q1
2021
Mar 31, 2020
($26.66M)
May 6, 2021
Q3
2020
Sep 30, 2019
($25.00M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($18.50M)
Aug 5, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.88M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($11.09M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($9.94M)
May 8, 2025
Q3
2025
Sep 30, 2024
($10.96M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($12.20M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($10.73M)
May 8, 2025
Q3
2024
Sep 30, 2023
($15.05M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($17.49M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($19.56M)
May 8, 2024
Q3
2023
Sep 30, 2022
($23.40M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($24.57M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($23.16M)
May 4, 2023
Q3
2022
Sep 30, 2021
($18.88M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($23.67M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($27.26M)
May 12, 2022
Q3
2021
Sep 30, 2020
($4.02M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
$6.58M
Aug 5, 2021
Q1
2021
Mar 31, 2020
($27.69M)
May 6, 2021
Q3
2020
Sep 30, 2019
($25.99M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($19.70M)
Aug 5, 2020